<<

HHS Public Health Emergency Medical Countermeasures Enterprise Stakeholders Workshop 2008 & BARDA Industry Day Participants

September 24−26, 2008 Crystal Gateway Marriott Arlington, VA

U.S. Department of Health and Human Services Assistant Secretary for Preparedness and Response Biomedical Advanced Research and Development Authority inside front cover blank PARTICIPANTS M. Javad Aman, PhD President and Chief Scientific Officer Katherine (Kay) Aaby, RN, BSN, MPH Integrated BioTherapeutics Inc. Nurse Manager [email protected] Montgomery County, Maryland Department of Health and Human Services Norman Anderson, PhD [email protected] President Viral Defense Foundation Abe Abramovich, BSEE, MSEE [email protected] Spacelabs Healthcare [email protected] Richard Andrews, BS, MS, SM David Adams, BSN, MA Chief Business Officer Director, Contingency Planning and Policy ProThera Biologics Office of Health Affairs [email protected] U.S. Department of Homeland Security [email protected] Russell Andrews, MS, RPh Chief Executive Officer Steven Adams, MPH NexGenisys Deputy Director [email protected] Division of Strategic National Stockpile Coordinating Office for Terrorism Preparedness and Edward Arcuri, PhD Emergency Response Chief Operating Officer Centers for Disease Control and Prevention VaxInnate U.S. Department of Health and Human Services [email protected] [email protected] Mary Ari, PhD Heidi Agostini, PhD, PMP Health Scientist Associate Director Centers for Disease Control and Prevention Botulinum Vaccine and Therapeutic Programs U.S. Department of Health and Human Services Emergent Product Development, Inc. [email protected] [email protected] Alexander Aristarkhov, PhD Ronald Aimes, PhD Director, Science & Technology Associate Director, Research and Development Exiqon, Inc. Peregrine Pharmaceuticals, Inc. [email protected] [email protected]

David Aimone Stuart Armstrong, BSc Assistant Director of Federal Procurement Defense Science and Technology Laboratory Buchanan Ingersoll & Rooney [email protected] [email protected] Rebecca Ashery, PhD Edson Albuquerque Consultant Chairman of the Department of Pharmacology and [email protected] Experimental Therapeutics University of Maryland Baltimore County Medical School Hugh Auchincloss, MD [email protected] Deputy Director National Institute of Allergy and Infectious Diseases Kate Alford, JD, BS National Institutes of Health Office of Health Affairs U.S. Department of Health and Human Services U.S. Department of Homeland Security [email protected] [email protected]

Bruce Altevogt, PhD Timothy Axtelle Senior Program Officer Vice President, Research and Development Institute of Medicine Implicit Bioscience [email protected] [email protected]

Amy Altman, PhD CAPT Judith L. Bader, MD Director, Extramural Research Office Senior Medical Advisor Luminex Corporation Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Jennifer Bryning Alton Office of Senator Richard Burr HELP Committee [email protected] 1 Timothy Baker, MPH Brian Bell Senior Consultant President Northrop Grumman Health IT Medical Conservation Devices, LLC [email protected] [email protected]

Shukal Bala, PhD Archana Belle, PhD Lead Microbiologist, Office of Antimicrobial Products Senior Scientist Division of Special Pathogen and Transplant Products Planet U.S. Food and Drug Administration [email protected] U.S. Department of Health and Human Services [email protected] Grant Belsham, BS Program Manager Michael Balady, PhD, MSPH Cangene Corporation Director for Acquisition Management Systems [email protected] Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response Steven Bennett, PhD U.S. Department of Health and Human Services WMD Risk Assessment Program Manager [email protected] U.S. Department of Homeland Security [email protected] Tali Bar-Shalom, PhD Program Examiner Carmela Benson Office of Management and Budget Ortho-McNeil Janssen Scientific Affairs, LLC Executive Office of the President [email protected] [email protected] Wendy Benson Lena A. Basile, PhD, JD Vice President President, Director of Research HX Diagnostics Neumedicines Inc. [email protected] [email protected] Kavita Berger, PhD Bill Basinger, BS, MS Project Director Chief Executive Officer America Association for the Advancement of Science Countervail Corporation [email protected] [email protected] Ruth Berkelman, MD Henry Bassman Rollins Professor and Director Vice President and Chief Business Officer Center for Public Health Preparedness and Research StormBio, LLC Rollins School of Public Health [email protected] Emory University [email protected] Frederick Batzold, PhD Director, Clinical Operations Bob Bernard Pharmaceutical Product Development, Inc. President, Chief Executive Officer [email protected] Ichor Medical Systems [email protected] Robert Becker, PhD Vice President, Business Development Diane Berry, PhD VaxInnate Chief Scientist [email protected] Office of Health Affairs U.S. Department of Homeland Security Steven Becker, PhD [email protected] Associate Professor of Public Health University of Alabama at Birmingham Kathleen Berst [email protected] Director, Developmental Program Integration CBMS – Joint Vaccine Acquisition Program Stefanie Bednarczyk U.S. Army Senior Manager, New Business U.S. Department of Defense Dupont Vaccine Company LLC, a CSC Company [email protected] [email protected] Stephen Berte, PhD Senior Management Consultant Skyline Integrated Technologies Enterprises [email protected]

2 Richard Besser, MD Luciana Borio, MD Director Senior Associate Coordinating Office for Terrorism Preparedness and Emergency Center for Biosecurity of the University of Pittsburgh Medical Response Center Centers for Disease Control and Prevention [email protected] U.S. Department of Health and Human Services [email protected] Jim Bowman, MD, MS Medical Officer George Bettinger, PhD Centers for Medicare and Medicaid Services Director, Product Development Operations U.S. Department of Health and Human Services University of Texas Medical Branch [email protected] [email protected] Deborah Brandon, BS Penelope Bevan Editor Department of Health www.birdflujourney.typepad.com United Kingdom [email protected] [email protected] Ken Brennan Walter Biederbick, PhD Weapons of Mass Destruction Coordinator Federal Information Centre for Biological Safety Fairfax County (Virginia) Police Department Robert Koch Institute [email protected] [email protected]

Gary Bignami Ann Brockhaus, MPH Director, Strategic Development Occupational Safety and Health Consultant PanThera Biopharma LLC ORC Worldwide [email protected] [email protected]

Peggy Binzer Stephen Brozak, MBA Partner Chairman and Chief Executive Officer McKenna, Long & Aldridge, LLP StormBio, Inc. [email protected] [email protected]

Peter Blain, PhD Greg Burel Professor of Environmental Medicine Director, Division of Strategic National Stockpile University of Newcastle Upon Tyne Coordinating Office for Terrorism Preparedness [email protected] and Emergency Response Centers for Disease Control and Prevention William Blakely, PhD U.S. Department of Health and Human Services Senior Scientist and Biodosimetry Program Advisor [email protected] Armed Forces Radiobiology Institute Uniformed Services University of the Health Sciences John P. Burke III U.S. Department of Defense Assistant Director, Public Health and Scientific Affairs [email protected] College of American Pathologists [email protected] Glenn Blanchette, MS, BS Regional Emergency Coordinator Roberta Carlin, MS, JD National Capital Region Executive Director Office of the Assistant Secretary for Preparedness and Response American Association on Health and Disability U.S. Department of Health and Human Services [email protected] [email protected] Calvin Carpenter, DVM James Blumenstock, MA Research Professor Chief Program Officer George Mason University Association of State and Territorial Health Offices [email protected] [email protected]

Jerold Blutman Miles Carroll, PhD Senior Technical Advisor Head of Research and Development DTRA CBM / Biological Diagnostics Health Protection Agency, United Kingdom U.S. Department of Defense [email protected] [email protected] Leslie Casey, PhD Tove Bolken, BS Executive Director, Preclinical Development and Head of Research Operations Immunobiology SIGA Technologies, Inc. Elusys Therapeutics, Inc. [email protected] [email protected] 3 Christine Cassan, PharmD John Cheronis, MD, PhD Technical Advisor, Public Health Emergencies Preparedness President and Chief Scientific Officer and Response Accuthera, Inc. French Health Ministry General Directorate [email protected] [email protected] Kelly Childress, JD David Cassatt, PhD Health Policy Specialist Program Officer Foley Hoag, LLP Division of Allergy, Immunology and Transplantation [email protected] National Institute of Allergy and Infectious Diseases National Institutes of Health Christine Chopard U.S. Department of Health and Human Services EPRUS (French Ministry of Health) [email protected] [email protected]

Drew Catron, PhD Susan Chu, MD Senior Scientist Executive Director Syntiron LLC ReadyMoms Alliance [email protected] [email protected]

Ajoy Chakrabarti, MBA, PhD Konstantin Chumakov, PhD Senior Director and Project Manager, AIG Associate Director for Research (acting) Emergent BioSolutions U.S. Food and Drug Administration [email protected] U.S. Department of Health and Human Services [email protected] William Chalgren, BS Marketing Manager Anita Cicero E-Z-EM, Inc. Secretary and Legal Counsel [email protected] Alliance for Biosecurity [email protected] Walter Chalkley Senior Editor Chad Claar, MPH, MBA, MA Thomson Reuters Chief, Public Health Emergency Response [email protected] Air Force Medical Operations Agency U.S. Department of Defense Paul Chaplin, PhD [email protected] Executive Vice President, Research and Development Chief Science Officer Rob Clark, MS Managing Director Deputy Chief Compliance Officer and Director of Government Bavarian Nordic GmbH Relations [email protected] St. Jude Children’s Research Hospital [email protected] Tara Chapman King & Spalding John Clerici, JD [email protected] Partner McKenna, Long & Aldridge LLP Steve Chatfield, PhD [email protected] Director, Centre for Emergency Preparedness and Response Health Protection Agency, United Kingdom Aaron Cohen [email protected] Vice President, Government and Political Affairs Kimbell & Associates Amy Chen [email protected] Associate Director XOMA (US) LLC Michelle Colby [email protected] Office of Science and Technology Policy Executive Office of the President Ping Chen, PhD [email protected] Project Officer, Office of Biodefense Research Affairs Division of Microbiology and Infectious Diseases LT COL Rodney Coldren, MD, MPH National Institute of Allergy and Infectious Diseases Center for Health Promotion and Preventive Medicine National Institutes of Health U.S. Army U.S. Department of Health and Human Services U.S. Department of Defense [email protected] [email protected]

4 Kenneth Cole, PhD Christine Czarniecki, PhD Director, Chemical and Biological Medical Defense Programs Chief, Office of Regulatory Affairs Office of the Special Assistant to the Secretary of Defense for Division of Allergy Immunology and Transplantation Chemical and Biological Defense Programs and Chemical National Institute of Allergy and Infectious Diseases Demilitarization Programs National Institutes of Health U.S. Navy U.S. Department of Health and Human Services U.S. Department of Defense [email protected] [email protected] Michael Czarny, PhD C. Norman Coleman, MD Director, Special Projects Associate Director, Radiation Research Program SAFC, Division of Sigma-Aldrich, Inc. National Cancer Institute [email protected] National Institutes of Health Senior Medical Advisor and Chief of the CBRN Team LT Col Stephen Dalal Office of the Assistant Secretary for Preparedness and Response Program Director, TMTI U.S. Department of Health and Human Services Defense Threat Reduction Agency [email protected] U.S. Department of Defense [email protected] Bill Colston, PhD Chief Executive Officer Dack Dalrymple, BA, JD QuantaLife, Inc. Principal [email protected] Dalrymple & Associates, LLC [email protected] Chris Colwell, MPP Senior Advisor James Davis, PhD, JD McKenna, Long & Aldridge, LLP Executive Vice President and General Counsel [email protected] Human Genome Sciences, Inc. [email protected] Charles Cong, BSc Program Manager Sybil D’Costa Cangene Corporation Beckman Coulter, Inc. [email protected] [email protected]

Francesca Cook, MPH Wenlin Deng, PhD, MD Vice President, Policy and Government Affairs RxBio, Inc. PharmAthene, Inc. [email protected] [email protected] Sheri Denkensohn, BS, JD Mark Cooke Special Assistant to the Inspector General Senior Director, Government Affairs Office of Inspector General PharmAthene, Inc. U.S. Department of Health and Human Services [email protected] [email protected]

Susan Cooper, MSN, RN Mark Dertzbaugh, PhD Commissioner Chief, Business Plans and Programs Tennessee Department of Health U.S. Army Medical Research Institute of Infectious Diseases [email protected] U.S. Department of Defense [email protected] Brooke Courtney, JD, MPH Associate Marianne Deschene Center for Biosecurity of the University of Pittsburgh Agence Française de Sécurité Sanitaire des Produits de Santé Medical Center [email protected] [email protected] Albert DiRienzo, BSCS Randall Culpepper, MD, MPH President and Chief Executive Officer Senior SME Consultant, Health Affairs Blue Highway U.S. Department of Defense [email protected] [email protected] Andrea DiCarlo, PhD John Curnutte Program Officer Chief Executive Officer Division of Allergy, Immunology and Transplantation 3-V Biosciences National Institute of Allergy and Infectious Diseases [email protected] National Institutes of Health U.S. Department of Health and Human Services [email protected] 5 Sally Dickens Anne Dumbrille, PhD [email protected] Fastrack [email protected] Richard Dirocco, PhD Chief Scientific Officer Michael Dunn, MD Secant Pharma, LLC Senior Medical Advisor [email protected] Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services Gary L. Disbrow, PhD [email protected] Chief, Vaccines and Therapeutics Biomedical Advanced Research and Development Authority Ivan Alekseevich Dyatlov Office of the Assistant Secretary for Preparedness and Response State Research Center for Applied Microbiology and Biotechnology U.S. Department of Health and Human Services Obolensk Moscow Region, Russian Federation [email protected] [email protected]

Daniel Dodgen, PhD Susan Eckert, MSN Director, Office of At-Risk Individuals, Behavioral Health, and Hu- Director man Services Coordination Washington Hospital Center Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Sharmain Edwards Public Health Training Manager Lyubov Domotenko, PhD American Samoa Department of Health State Research Center for Applied Microbiology and Biotechnology [email protected] [email protected] Richard Egan, PhD John Dong, MD, PhD Executive Director, Immunoassay Development President and CEO Nanogen, Inc. GenPhar, Inc. [email protected] [email protected] Michael Eichberg, PhD Jerome A. Donlon, MD, PhD Associate Director, Business Development Chief Science Advisor Achaogen, Inc. Biomedical Advanced Research and Development Authority [email protected] Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services Fuad El-Hibri [email protected] Emergent BioSolutions, Inc. [email protected] William Dowling, PhD S&T Manager Diana Elkis Defense Threat Reduction Agency PRTM U.S. Department of Defense [email protected] [email protected] Gary Elliott, BA, MS, MD Diane Doyle, PhD(c), MS, BS Information Systems Security Officer Disaster Preparedness Coordinator U.S. Department of Homeland Security Inova Health System [email protected] [email protected] Patricia Elliott, JD, MPH Kenneth Dretchen, PhD Troutman Sanders, LLP Professor and Chair, Department of Pharmacology [email protected] Georgetown University [email protected] Steven Engle Chairman and Chief Executive Officer Boro Dropulic, PhD Founder, President, and Chief Scientific Officer XOMA (US) LLC Lentigen Corporation [email protected] [email protected] Alan Epstein, MD, JD, MBA Stephanie Dulin, MBA Senior Medical Radiation Advisor Chief, Program Preparedness Branch Chemical Biological Medical Systems Centers for Disease Control and Prevention U.S. Department of Defense U.S. Department of Health and Human Services [email protected] [email protected]

6 Eric Espeland, PhD Bill Fitzgerald, BA Senior Science Manager Senior Advisor, Biomedical Preparedness CBMS- Joint Vaccine Acquisition Program American Red Cross U.S. Army [email protected] U.S. Department of Defense [email protected] Patrick Flavin, JD Chief Legal Counsel Matthew Ewert, MS CT (ASCP) Advanced Life Sciences President and Chief Executive Officer [email protected] Imigene, Inc. [email protected] Christopher Fletcher, MD, MPH Director of Emergency Preparedness Ann Farese, MS Metro Public Health Department of Nashville and Davidson Research Associate County, Tennessee University of Maryland [email protected] [email protected] Ramon Flick, PhD Victoria Felise, RN Senior Director of Vaccine Development Preparedness Program Nurse BioProtection Systems Corporation U.S. Department of Health and Human Services [email protected] [email protected] Margaret Fowke National Weather Service Jerold Fenner Office of the Assistant Secretary for Preparedness and Response National Oceanic and Atmospheric Administration U.S. Department of Health and Human Services [email protected] [email protected] Joseph Fratantoni, MD Vice President Valentina Feodorova Medical Affairs and Clinical Development Saratov Scientific and Research Veterinary Station MaxCyte, Inc. Russian Academy of Agricultural Sciences [email protected] [email protected] Douglas Freitag, MSBE, MSME Stefan Fernandez, PhD President Deputy Chief, Department of Immunology Bayside Materials Technology United States Army Medical Research Institute of Infectious [email protected] Diseases U.S. Department of Defense Gregory Frykman, MD [email protected] Managing Member Framework Therapeutics, LLC Paul Ferrari, JD [email protected] Principal Hyman, Phelps & McNamara, P.C. Thomas R. Fuerst, PhD [email protected] Senior Science Advisor Office of the Assistant Secretary for Preparedness and Response James Fett, PhD, MBA U.S. Department of Health and Human Services Consultant [email protected] Avila Therapeutics, Inc. [email protected] Bradley Fuhrman, MD Chief, Pediatric Critical Care David Fick, MS Women and Children’s Hospital of Buffalo Director, Medicinal Chemistry [email protected] Cenomed BioSciences, LLC [email protected] Marc Gaal Sigma-Aldrich, Inc. Elliott Fineman, BA, MS, JD [email protected] President and Chief Executive Officer Planet Biotechnology, Inc. Timothy K. Gallaher, PhD [email protected] Director of Pharmacology and Proteomics Neumedicines, Inc. Aaron Firoved, PhD [email protected] Professional Staff U.S. Senate Philomena Gambale, MS [email protected] Project Manager University of Pittsburgh Medical Center [email protected] 7 Emily Gardiner, MPA Frank Gottron, PhD Senior Analyst Specialist in Science and Technology Policy U.S. Government Accountability Office Congressional Research Service [email protected] U.S. Library of Congress [email protected] Susan Geiger Marcy Grace, PhD Partner Project Officer K&L Gates, LLP Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Bruce Gellin, MD, MPH Director, National Vaccine Program Office Brandon Graham, BS U.S. Department of Health and Human Services Associate Director [email protected] Office of Homeland Security George Washington University David Gencarelli, JD [email protected] President Gencarelli Group Dwayne Grant [email protected] Office of Evaluations and Inspections Office of Inspector General Daniel Gillet, PhD U.S. Department of Health and Human Services Coordinator for Biology for the French RNBC Program [email protected] Adjoint au Chef du Service d’Ingénierie Moléculaire des Protéines Alan Greenthal Institut de Biologie et des Technologies de Saclay Manager of Government Operations Commissariat à l’Energie Atomique, France [email protected] [email protected]

Kevin Gilligan, PhD Elliott Grollman, MA Branch Chief, Antiviral Drugs for Pandemic Influenza Commander Biomedical Advanced Research and Development Authority Federal Protective Service Office of the Assistant Secretary for Preparedness and Response U.S. Department of Homeland Security U.S. Department of Health and Human Services [email protected] [email protected] Andrei Gudkov Sadanand Gite Roswell Park Cancer Institute First Light Biosciences [email protected] [email protected] Veeresa Gududuru, PhD Tom Gladstone, MS, BS RxBio, Inc. Senior Associate [email protected] Booz Allen Hamilton [email protected] Robert Guidos, JD Director, Public Policy and Government Relations Michael Goldblatt, PhD, JD Infectious Diseases Society of America President and Chief Executive Officer [email protected] Functional Genetics, Inc. [email protected] Robert Gundel, PhD Vice President, Research Stanley Goldman, PhD Elusys Therapeutics, Inc. Director of Research [email protected] Genetic Chemistry, Inc. [email protected] James Guyton, MA Principal, Public Health & Biodefense William Goodwin, BS, MS PRTM Director, Strategic Biothreat Business Development [email protected] Cepheid [email protected] Andre Habel, PhD Business Development Executive Susan Gorman, PharmD, MS Stabilitech, Ltd. Associate Director for Science [email protected] Division of Strategic National Stockpile Centers for Disease Control and Prevention Peter Hadrovic U.S. Department of Health and Human Services Chief Commercial Officer [email protected] Adamas Pharmaceuticals, Inc. [email protected] 8 Bassam Hallis, PhD Diane Heck, PhD General Project Manager Professor and Chair Health Protection Agency, United Kingdom New York Medical College School of Public Health [email protected] [email protected]

Mervyn Hamer Bill Helming Iomai Corporation PRTM [email protected] [email protected]

Edward J. Handler, III, BS, JD David Helton, BS President President, Chief Executive Officer, Chief Science Officer StormBio, Inc. Cenomed BioSciences, LLC [email protected] [email protected]

Drew Hannaman Jack Herrmann, MSEd, NCC, LMHC Vice President, Research and Development Senior Advisor, Public Health Preparedness Ichor Medical Systems National Association of County and City Health Officials [email protected] [email protected] Jennifer Hannesschlager, PhD, MPH Senior Advisor Alexander Heyl Chief Executive Officer McKenna, Long & Aldridge, LLP Heyltex Corporation [email protected] [email protected] Kevin Hanretta Deputy Assistant Secretary for Emergency Management Sally Hojvat, MSc, PhD U.S. Department of Veterans Affairs Director, Division of Microbiology Devices [email protected] Office of In Vitro Diagnostic Devices Center for Devices and Radiological Health Julie Hantman, MS U.S. Food and Drug Adminstration Senior Program Officer for Public Health U.S. Department of Health and Human Services Infectious Diseases Society of America [email protected] [email protected] Robert House, PhD Chandresh Harjivan, PharmD President Principal DynPort Vaccine Company LLC, a CSC Company PRTM [email protected] [email protected] Pamela Howorth, BA Randy Harper, ARM, MS Market Manager Area Safety Manager Battelle HCR Manor Care [email protected] [email protected] Dennis Hruby, PhD Elisa Harris, MPhil Chief Scientific Officer Senior Research Scholar SIGA Technologies, Inc. Center for International and Security Studies [email protected] University of Maryland, College Park [email protected] Edbert Hsu, MD, MPH Director of Training Zsolt Harsanyi, PhD Office of Critical Event Preparedness and Response Chief Executive Officer Johns Hopkins University Exponential Biotherapies, Inc. [email protected] [email protected]

Richard Hatchett, MD Carole Hudgings, PhD Associate Director for Radiation Countermeasures Research Senior Advisor and Emergency Preparedness National Institute of Allergy and Infectious Diseases National Institute of Allergy and Infectious Diseases National Institutes of Health National Institutes of Health U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected] Rosemary Humes Charles Hebert, PhD Senior Advisor, Scientific Affairs Southern Research Institute Association of Public Health Laboratories [email protected] [email protected] 9 Kirsten Hundrup James James, MD, DrPH, MHA Controller Director Bavarian Nordic A/S Center for Public Health Preparedness and Disaster Response [email protected] American Medical Association [email protected] Jay Hunter, BS, CHS Research Administrator David Jarrett, MD University of Maryland School of Medicine Deputy and Medical Director [email protected] Chemical and Biological Defense and Chemical Demilitarization Office of the Secretary of Defense Jean Hu-Primmer, MS U.S. Department of Defense Senior Scientist and Program Manager for Pandemic Influenza [email protected] Center for Biological Evaluation and Research U.S. Food and Drug Administration Linda Jenckes U.S. Department of Health and Human Services President [email protected] Linda Jenckes and Associates [email protected] Noreen Hynes, MD, MPH, DTM&H Medical Director, International Travel Medicine Service David Jett, PhD Johns Hopkins University School of Medicine Program Director, Counterterrorism Research [email protected] National Institute of Neurological Disorders and Stroke National Institutes of Health Johan Inborr, PhD U.S. Department of Health and Human Services Sales Director [email protected] Vironova AB [email protected] George Jiang, MD Booz Allen Hamilton Thomas Inglesby, MD [email protected] Chief Operating Officer and Deputy Director Center for Biosecurity of the University of Pittsburgh Medical Mary Jo Jindra, BS Center Program Director [email protected] University of Pittsburgh Medical Center [email protected] Alexander Ischenko State Research Institute of Highly Pure Biopreparations Alan Johnson St. Petersburg, Russian Federation PanThera Biopharma, LLC [email protected] [email protected] Joany Jackman, PhD Senior Scientist Nina Johnson, BA Johns Hopkins Applied Physics Laboratory Managing Director [email protected] Sydion [email protected] Pamelia Jackson Community Health Nurse Virginia Johnson, PhD Emergency Preparedness and Response Vice President, Regulatory Affairs Montgomery County (MD) Department of Health and Human Emergent BioSolutions Services [email protected] [email protected] B. Tilman Jolly, MD Sean Jackson Associate Chief Medical Officer for Medical Readiness Manager U.S. Department of Homeland Security PRTM [email protected] [email protected] Jeff Jones, PhD Rick Jaffe, PhD, MT (ASCP) Director Business Development ANSER, Inc. Senior Medical Advisor in Support of OSA Pharmathene (CBD & CDP) [email protected] U.S. Department of Defense [email protected] Robert L. Jones, PhD Chief, Inorganic and Radiation Analytical Toxicology Branch Christopher Jahraus, MD Centers for Disease Control and Prevention Chief Medical Officer U.S. Department of Health and Human Services Assurance Oncology Services, LLC [email protected] [email protected] 10 Jean-René Jourdain, PharmD, PhD John Kenten, PhD Head, Internal Dosimetry Department Scientific Director Institut de Radioprotection et de Sûreté Nucléaire Meso Scale Diagnostics jean-rené[email protected] [email protected]

James Jubilee, MS Laura Kilpatrick, MA HHS BTEP Program Manager Research Analyst International Science and Technology Center McKenna, Long & Aldridge, LLP [email protected] [email protected]

Robert P. Kadlec, MD Hye-Joo Kim, PharmD Special Assistant to the President for Homeland Security Senior Program Management Officer Senior Director, Biodefense Policy Centers for Disease Control and Prevention Homeland Security Council U.S. Department of Health and Human Services The Executive Office of the President [email protected] [email protected] Paul Kim, MPP, JD Florence Kaltovich, MS, MHS, RAC Partner Vice President, Regulatory Affairs and Quality Foley Hoag, LLP Summit Drug Development Services [email protected] [email protected] Randall Kincaid, PhD Joseph Kaminski, MD Veritas, Inc. Medical Officer [email protected] National Institute of Allergy and Infectious Diseases National Institutes of Health Michael Kinch, PhD U.S. Department of Health and Human Services Vice President, Research and Development [email protected] Functional Genetics, Inc. [email protected] Brian Kamoie, JD, MPH Deputy Assistant Secretary for Preparedness and Response Alan King, DVM, PhD Director, Office of Policy, Strategic Planning, and Communications Vice President U.S. Department of Health and Human Services Cyto Pulse Sciences, Inc. [email protected] [email protected]

Espen Kateraas Irena Kirman, MD, PhD Bavarian Nordic, Inc. Project Manager [email protected] Elusys Therapeutics, Inc. [email protected] Deborah Katz Deputy Director, Office of Biodefense Research Affairs Oleg Kiselev Division of Microbiology and Infectious Diseases Academic Secretary National Institute of Allergy and Infectious Diseases Research Institute of Influenza National Institutes of Health [email protected] U.S. Department of Health and Human Services [email protected] Maureen Kitchelt, BA, MBA Vice President Rebecca Katz, PhD, MPH ACS Federal Solutions Assistant Research Professor [email protected] George Washington University [email protected] William Klenke, MS Manager Azeb Kebede-Solomon Noblis Regulatory Affairs Specialist [email protected] P3S Corporation [email protected] Brennan Klose, PhD Project Leader Unither Virology Mike Kelly, BS, MSOR [email protected] Joint Requirements Office Joint Chiefs of Staff Harry Knight U.S. Department of Defense Emergency Management Officer [email protected] Office of Naval Intelligence U.S. Department of Defense [email protected] 11 Hon-Sum Ko, MD Peter Kyriacopoulos Medical Officer Director of Public Policy U.S. Food and Drug Administration Association of Public Health Laboratories U.S. Department of Health and Human Services [email protected] [email protected] Kim LaCour Gregory Koblentz, PhD Business Development Deputy Director, Biodefense Graduate Program Northrop Grumman Corporation George Mason University [email protected] [email protected] Clifton Lacy, MD Yakov Kogan, PhD Center Director, Robert Wood Johnson Medical School Chief Operating Officer University of Medicine and Dentistry of New Jersey Biolabs, Inc. [email protected] [email protected] Vafa Lahidji, BS Carolyn Korman, PhD Associate Director Senior Health Policy Analyst XOMA (US) LLC U.S. Government Accountability Office [email protected] [email protected]

MAJ Leonard Kosicki Joe Larsen, PhD JSG Executive Officer S&T Manager U.S. Department of Defense Defense Threat Reduction Agency [email protected] U.S. Department of Defense [email protected] Gerald Kovacs, PhD Acting Associate Director, Project BioShield and CBRN Programs Jeffrey Laskin, PhD Biomedical Advanced Research and Development Authority Professor and Chief Office of the Assistant Secretary for Preparedness and Response Robert Wood Johnson Medical School U.S. Department of Health and Human Services University of Medicine and Dentistry of New Jersey [email protected] [email protected]

Leo Krieg, MS Matthew Lawlor, PhD Vice President Program Analyst Biokinetics, Inc. Biomedical Advanced Research and Development Authority [email protected] Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services Vadim Krivokrysenko [email protected] Cleveland BioLabs, Inc. [email protected] Ross LeClaire, DVM, PhD Director of Defense Studies Jon Krohmer, MD, FACEP Lovelace Respiratory Research Institute Acting Assistant Secretary and Chief Medical Officer [email protected] Office of Health Affairs U.S. Department of Homeland Security Sam Lee, PhD [email protected] Director, Pandemic Influenza Preparedness sanofi pasteur Mary Kruger, BS Senior Executive Service [email protected] Office of Policy, Strategic Planning and Communications Office of the Assistant Secretary for Preparedness and Response Timothy Leeth, BA, CPA U.S. Department of Health and Human Services Consultant [email protected] Spacelabs Healthcare, Inc. [email protected] SGT David Kuhar Fairfax County Criminal Justice Academy Marie Legaspi, MHSA Fairfax County (Virginia) Police Department Public Health Analyst [email protected] Bureau of Primary Health Care Health Resources and Services Administration Michael Kurilla, MD, PhD U.S. Department of Health and Human Services Director, Office of Biodefense Research Affairs [email protected] Division of Microbiology and Infectious Diseases Associate Director for Biodefense Product Development National Institute of Allergy and Infectious Diseases U.S. Department of Health and Human Services [email protected] 12 Brad Leissa, MD Mark Logomasini Deputy Director, Office of Counterterrorism and Emergency Sigma-Aldrich, Inc. Coordination [email protected] Center for Drug Evaluation and Research U.S. Food and Drug Administration Dale Lombardi, MsBME U.S. Department of Health and Human Services Chief Executive Officer [email protected] Secant Pharma [email protected] Rachel Levinson Director, Government and Industry Liaison Pascal Longchamp, PhD, MBA Biodesign Institute at Arizona State University Vice President, Business Development [email protected] Evolva - Genetic Chemistry, Inc. [email protected] Clement Lewin, PhD, MBA Head, Strategic Immunization Planning Lillian Lou, PhD Novartis Vaccines and Diagnostics Maxygen, Inc. [email protected] [email protected]

Shulamit Lewin, MHS Maribeth Love Program Manager Deputy Director for Logistics International Center to Heal Our Children Office of Preparedness and Emergency Operations Children’s National Medical Center U.S. Department of Health and Human Services [email protected] [email protected]

Sheng Li, DVM Paul Lovendale Project Officer, Pandemic Influenza Program President and Chief Executive Officer Biomedical Advanced Research and Development Authority Radeco, Inc. Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Patrick Lu, PhD President and Chief Executive Officer George Liao, MS Sirnaomics, Inc. Senior IT Policy Planner [email protected] U.S. Department of Veterans Affairs [email protected] Joseph Lucas, BA Senior Vice President of Government Affairs Nigel Lilley BioProtection Systems Corporation Director, Strategic Development [email protected] Cangene Corporation [email protected] Chuck Ludlam, JD [email protected] Carol D. Linden, PhD Principal Deputy Director Scott Luginbill Biomedical Advanced Research and Development Authority Legislative Correspondent Office of the Assistant Secretary for Preparedness and Response Office of Senator Richard Burr U.S. Department of Health and Human Services [email protected] [email protected] RADM Boris Lushniak, MD, MPH Alan Liss, PhD Assistant Surgeon General, U.S. Public Health Service Deputy Director, Regulatory and Quality Affairs Assistant Commissioner, Counterterrorism Policy Biomedical Advanced Research and Development Authority U.S. Food and Drug Administration Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected] Ronald Lynch, MBA Brian Livingston, PhD President Director, Biodefense Programs Countervail Corporation Ichor Medical Systems [email protected] [email protected] Shirley Mabry Alicia Livinski, MPH, MA Logistics Branch Chief Biomedical Librarian Division of Strategic National Stockpile National Institutes of Health Library Centers for Disease Control and Prevention U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected]

13 CAPT James Macrellis Monique K. Mansoura, PhD U.S. Army Director, Division of Policy, Planning, and U.S. Department of Defense Requirements [email protected] Acting Deputy Director, Biomedical Advanced Research and Development Authority CDR Carmen Maher, BSN, MA, RN, RAC Office of the Assistant Secretary for Preparedness and Response Policy Analyst U.S. Department of Health and Human Services Office of Counterterrorism and Emerging Threats [email protected] Office of the Commissioner U.S. Food and Drug Administration John Manzello U.S. Department of Health and Human Services President and Chief Executive Officer [email protected] Promosome, LLC [email protected] Bert Maidment, PhD Associate Director for Product Development Maria Julia Marinissen, PhD Division of Allergy, Immunology, and Transplantation Senior Program Analyst National Institute of Allergy and Infectious Diseases International Partnerships and Initiatives Team National Institutes of Health Office of Medicine, Science and Public Health U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Wolf Maier, DVM, PhD European Commission Mariana Marques, MA [email protected] Director, Research Program Development University of Maryland School of Medicine Tomohiko Makino, PhD [email protected] International Risk Management Coordinator Office of Health Emergency Preparedness and Response Heather Marshall-Heyman, PhD Health Science Division, Minister’s Secretariat Chief Program Officer Japanese Ministry of Health, Labour and Welfare Vironova AB [email protected] [email protected] Jerry Marzouk, MSEE Craig Malzahn, BS, MS Electrical Engineer Program Leader, Smart Transitions Human Genome Sciences, Inc. [email protected] [email protected] Mary Masters, MSPH, MS Robert Mandell, PhD Senior Study Director BioProtection Systems Corporation Westat [email protected] [email protected]

Lesia Mandzia, MSW, MA James Matthews, BS, MS, PhD Senior Analyst Senior Director, Health and Science Policy U.S. Government Accountability Office sanofi pasteur [email protected] [email protected]

David Mann Vincent Mauro, PhD Chief Executive Officer Lead Scientist, Promosome, LLC Vascular BioSciences Associate Professor, Department of Neurobiology [email protected] The Scripps Research Institute [email protected] Ronald Manning, PhD Branch Chief, Chemical, Radiological, and Robert Mauskapf Nuclear Medical Countermeasures State SNS Planner Biomedical Advanced Research and Development Authority Virginia State Department of Health Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Iva Maxwell, PhD Meso Scale Diagnostics Marc Mansour, PhD [email protected] Lead Scientist Promosome, LLC Keith Mayo, MS, MA [email protected] S&T Program Manager Fulcrum Corporation [email protected] 14 Mary Mazanec, MD, JD Marian McKee, PhD Acting Director, Office of Medicine, Science, and Public Health Director, Microbiology Collections Office of the Assistant Secretary for Preparedness and Response ATCC U.S. Department of Health and Human Services [email protected] [email protected] LT Mark McKinnon, MS, PA-C Nadezhda Mazina Executive Assistant Manager, International Scientific Project Office of the Assistant Secretary for Preparedness and Response Kirov State Medical Academy U.S. Department of Health and Human Services [email protected] [email protected]

Nancie McAnaugh, MSW Matthew Meldorf, MD Deputy Department Director Senior Program Director Missouri Department of Health and Senior Services PharmAthene, Inc. [email protected] [email protected]

James McArdle, PhD Gretchen Michael Program Manager, BEIR Communications Director ATCC Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Grant McClarty, PhD Vice President, Research and Development Scott Middlekauff, MS, PA-C Cangene Corporation Branch Chief, Office of Health Affairs [email protected] U.S. Department of Homeland Security [email protected] Joel McCleary Four Seasons Ventures Jeremy Middleton [email protected] Vice President, Corporate Development Elusys Therapeutics, Inc. Wes McConnell, BA, MBA [email protected] Director of Government Reporting Bavarian Nordic, Inc. Thi-Sau Migone, PhD [email protected] Senior Director Human Genome Sciences, Inc. Martin McCool RxBio, Inc. [email protected] [email protected] Aubrey Miller, MD, MPH W. Shannon McCool, DPh Chief Medical Officer President and Chief Executive Officer U.S. Food and Drug Administration RxBio, Inc. U.S. Department of Health and Human Services [email protected] [email protected]

CAPT Ron McCuan, DMD, JD Matthew Minson, MD Public Health Analyst Senior Medical Officer for Strategic Initiatives National Institute of Corrections, Federal Bureau Office of the Assistant Secretary for Preparedness and Response of Prisons U.S. Department of Health and Human Services U.S. Department of Justice [email protected] [email protected] Jennifer Mitcham, PhD Susan McCune, MD Director, Program Management U.S. Food and Drug Administration Spaltudaq Corporation U.S. Department of Health and Human Services [email protected] [email protected] Samir Mody Wesley McDermott, MSPH Director, Scientific Affairs Public Health Emergency Preparedness Ortho-McNeil-Jasen Pharmaceuticals, Inc. Fairfax County (Virginia) Health Department [email protected] [email protected] Mary Moreno, BA Kelly McKee, MD, MPH Audit Manager, Office of Audit Services Vice President Office of Inspector General Quintiles Public Health and Government Services U.S. Department of Health and Human Services [email protected] [email protected]

15 Carolina Morgan, MPA Romy Nocera, PhD Senior Policy Analyst Medical Science Liaison, Northeast U.S. Government Accountability Office Valeant Pharmaceuticals International [email protected] [email protected]

Dmitry V. Morozov Jeffrey Nordstrom, PhD Chief Executive Officer Director, Product Development Biocad, Ltd. Petrovo-Dalneye MacroGenics, Inc. [email protected] [email protected]

Stephen Morse, PhD Benjamin Novak, MSPPM Professor, Epidemiology Program Analyst Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] MAJ Larry Moser Fairfax County (Virginia) Police Ed Nuzum, DVM, PhD [email protected] Biological Product Development Section Dawn Myscofski, PhD, MBA Office of Biodefense Research Affairs Deputy Director, Division of Policy, Planning and Requirements Division of Microbiology and Infectious Diseases Biomedical Advanced Research and Development Authority National Institute of Allergy and Infectious Diseases Office of the Assistant Secretary for Preparedness and Response National Institutes of Health U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected]

Gary Nabors Steven O’Brien Emergent BioSolutions, Inc. Chemical, Biological, Radiological, Nuclear and [email protected] Explosives/PanFlu Program American National Red Cross Mazina Nadezhda [email protected] Manager, International Scientific Project Kirov State Medical Academy Jules O’Rear, PhD [email protected] Lead Microbiologist U.S. Food and Drug Administration Nikhil Natarajan U.S. Department of Health and Human Services Associate Director jules.o’[email protected] New York State Department of Health [email protected] Dani Organ Fabiani and Company Linda Neff, PhD [email protected] Senior Science Officer Centers for Disease Control and Prevention Christie Orschell, PhD U.S. Department of Health and Human Services Director, GLP Stem Cell Laboratory [email protected] Indiana University School of Medicine [email protected] Mua Nguye Leadership Investor Federal Trade Commission Luis Ortega, MD [email protected] Command Surgeon U.S. Coast Guard Deployable Operations Group Richard Nidel, MS U.S. Department of Homeland Security Acting Product Manager [email protected] Joint Vaccine Acquisition Program U.S. Department of Defense Rebecca Osborne, BSc [email protected] Operations and Project Manager Implicit Bioscience Daisy Guha Niyogi, PhD, MBA [email protected] Associate PRTM Tara O’Toole, MD, MPH [email protected] Chief Executive Officer and Deputy Director Center for Biosecurity of the University of Pittsburgh Medical Bethany Noble Center Director, Federal Procurement [email protected] Buchanan, Ingersoll, and Rooney [email protected]

16 Todd Pantezzi Todd Piester Computer Sciences Corporation Response Branch Chief [email protected] Division of Strategic National Stockpile Coordinating Office for Terrorism Preparedness and Emergency Stephen Papagiotas, MPH Response Public Health Advisor / Emergency Coordinator Centers for Disease Control and Prevention Centers for Disease Control and Prevention U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected] Joseph Pignataro, BS Gerald W. Parker, DVM, PhD, MS Chief of Police Principal Deputy Assistant Secretary for Preparedness and Centreville (Virginia) Police Department Response [email protected] U.S. Department of Health and Human Services [email protected] Lori Pilcher, MBA Assistant Inspector General MG John S. Parker, MD, FACS, FCCP (U.S. Army, Retired) Office of Inspector General Member, National Biodefense Science Board U.S. Department of Health and Human Services Chairperson, NBSB Markets and Sustainability Working Group [email protected] [email protected] Segaran Pillai, PhD Andrew T. Pavia, MD Chief Medical and Science Advisor, Science & Technology Member, National Biodefense Science Board U.S. Department of Homeland Security Chairperson, NBSB Pandemic Influenza Working Group [email protected] Co-Chairperson, NBSB Personal Preparedness Working Group Heidi Pinyerd [email protected] Scientific Program Manager ImmuneRegen® BioSciences, Inc. Michael L. Perdue, PhD [email protected] Deputy Director, Division of Influenza and Emerging Diseases Biomedical Advanced Research and Development Authority Alfred Piombino, BS, MPA Office of the Assistant Secretary for Preparedness and Response Emergency Preparedness Planner U.S. Department of Health and Human Services Chester County Health Department [email protected] [email protected]

Nicki Pesik, MD Louise Pitt, PhD Medical Officer Director, Center for Aerobiological Sciences Centers for Disease Control and Prevention U.S. Government Accountability Office U.S. Department of Health and Human Services [email protected] [email protected] Gennady Platoff, PhD Danielle Peters, MA Chemical, Biological, Radiological and Nuclear Consultant Scientific Advisor Fabiani & Company Office of the Director/OMO/OBR [email protected] National Institute of Allergy and Infectious Diseases National Institutes of Health Michael Peters U.S. Department of Health and Human Services Regulatory Affairs Specialist [email protected] American College of Radiology [email protected] Robert Polans Senior Director, Strategic Markets James Petro, PhD, MSSI Valeant Pharmaceuticals International Director for Biological and Chemical Defense Policy [email protected] White House Homeland Security Council Executive Office of the President Andrew Pope, PhD [email protected] Director, Board on Health Sciences Policy Institute of Medicine Joan Pfinsgraff, MD [email protected] Director, Health Intelligence iJET International Elizabeth Posillico, PhD [email protected] President and Chief Executive Officer Elusys Therapeutics, Inc. [email protected]

17 Joanna Prasher, PhD Jonathan Rayner, PhD Senior Policy Analyst Principal Scientist Biomedical Advanced Research and Development Authority Midwest Research Institute Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Laurie Realmuto, BS Vice President, Research and Development Beverly Pritchett, MHA WBB Securities, LLC Senior Deputy Director [email protected] District of Columbia Department of Health [email protected] Garry Redlich Implicit Bioscience Arthur Przbybl [email protected] President and Chief Executive Officer Akorn Jean D. Reed, SES [email protected] Special Assistant to the Secretary of Defense for Chemical and Biological Defense and Chemical Demilitarization Programs John Quackenboss Office of the Assistant to the Secretary of Defense (Nuclear, President Chemical, and Biological Programs) L&Q International, Inc. U.S. Department of Defense [email protected] [email protected]

Patricia Quinlisk, MD, MPH John Repine Chairperson, National Biodefense Science Board Health Sciences Program [email protected] University of Colorado, Denver [email protected] Beth Rada Senior Associate Eric Richman XOMA (US) LLC Senior Vice President [email protected] Business Development and Strategic Planning PharmAthene, Inc. Sara Radcliffe, MPH, MP [email protected] Vice President Science and Regulatory Affairs Patrick Riordan, BA Biotechnology Industry Organization Vice President, Government Sales [email protected] Moldex-Metric, Inc. [email protected] Abid Rahman, PhD Associate Chief Craig Robinson Emergency Management Healthcare Group Executive Director and Chief Operating Officer U.S. Department of Veterans Affairs National Acquisition Center [email protected] U.S. Department of Veterans Affairs [email protected] Joanie Rainey, MS Clinical Director, Force Health Protection James Robinson, BS, MS U.S. Army Medical Department Activity Vice President, Technical and Quality Operations U.S. Department of Defense Novavax, Inc. [email protected] [email protected]

Narayani Ramakrishnan, PhD Robin A. Robinson, PhD Program Officer Deputy Assistant Secretary for Preparedness and Response National Institute of Allergy and Infectious Diseases Director, Biomedical Advanced Research and Development National Institutes of Health Authority U.S. Department of Health and Human Services U.S. Department of Health and Human Services [email protected] [email protected]

Jacqueline Rams James M. Robl, PhD Director President Southern Research Institute Hematech, Inc. [email protected] [email protected]

Urban Ramstedt, PhD Eric Rose, MD Chief Scientist Chief Executive Officer Unither Virology SIGA [email protected] [email protected] 18 Jeannette Rosolowich Andres Salazar, MD Senior Director, Contract Management Chairman, Chief Executive Officer, and Scientific Director Cangene Corporation Oncovir [email protected] [email protected]

Darren Ross Jose Saldana Project Manager National Heart and Lung Institute Cangene Corporation Imperial College, London [email protected] [email protected]

Michelle Ross, DVM, MS, PhD Emad Samad Martin, Blanck & Associates WBB Securities [email protected] [email protected]

Jeff Rossio, PhD David Sander, BS, CSM Research and Development Manager Command Safety Officer Invitrogen Federal Systems Deployable Operations Group [email protected] U.S. Coast Guard U.S. Department of Homeland Security Andrew Roszak, JD, MPA, EMT-P [email protected] Fellow, David A. Winston Health Policy Fellowship Southern Illinois University Scott Santibañez, MD, MPHTM [email protected] Medical Officer and Senior Advisor for Vulnerable Populations Centers for Disease Control and Prevention Lisa D. Rotz, MD U.S. Department of Health and Human Services Director, Division of Preparedness and Response [email protected] National Center for Preparedness, Detection, and Control of Infectious Diseases Laura Saward Coordinating Center for Infectious Diseases Director of Bioanalytical Research Centers for Disease Control and Prevention Cangene Corporation U.S. Department of Health and Human Services [email protected] [email protected] CAPT Leigh Sawyer, DVM, MPM Andres Ruiz Executive Director, National Biodefense Science Board University of Texas at Austin Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Alexander Ryzhikov, PhD Head of Department for Vaccines and Antivirals Rachana Saxena, PhD State Research Center of Virology and Biotechnology Scientist Vector XOMA (US) LLC [email protected] [email protected]

John Sabat Patrick Scannon, MD, PhD Vice President, National Accounts and Trade Relations Chief Biotechnology Officer Akorn XOMA (US) LLC [email protected] [email protected]

Carol Sabourin, PhD Sergey Schelkunov Chief Scientist VECTOR Battelle [email protected] [email protected] Helen Schiltz, PhD Royden Saha, MS Program Officer Coordinator National Institute of Allergy and Infectious Diseases North Carolina Department of Health National Institutes of Health [email protected] U.S. Department of Health and Human Services [email protected] Victor Salamanca, MD, MPH Senior Policy Analyst Libby Schindler, PharmD Office of the Assistant Secretary of Defense Acting Chief, Homeland Medical Plans U.S. Department of Defense Air Force Medical Operations Agency [email protected] U.S. Department of Defense [email protected]

19 Ken Schoultz, BS Wendy Shelton Industrial Hygienist Fabiani and Company Virginia Department of Health [email protected] [email protected] Tom Shin, MS, PMP Mark Schroeder Manager, Vaccines Contracting Senior Vice President Government Group Baxter Healthcare Corporation Tunnell Consulting [email protected] [email protected] Roxanne Shively, MS, MT (SM) Diane Schutle, MA Project Officer, Biomedical Advanced Research and Principal Development Authority Diane Schulte & Associates Office of the Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Justina Schwemberger, MS Health Services Officer Ted Shoneck, MBA National Institute of Allergy and Infectious Diseases Managing Director National Institutes of Health Tunnell Government Services U.S. Department of Health and Human Services [email protected] [email protected] Hal Siegel, PhD Leah Scott, BSc Chief Scientific Officer Defense Science and Technology Laboratory ImmuneRegen BioSciences [email protected] [email protected]

Richard A. Serino, EMT-P George Sigal, PhD Chief of Department, Boston (Massachusetts) Emergency Meso Scale Diagnostics, LLC Medical Services [email protected] Assistant Director, Boston Public Health Commission Director, Boston Metropolitan Medical Response System Benjamin Sili [email protected] Public Health Preparedness Training Manager American Samoa Department of Health Jui Shah, PhD [email protected] Senior Regulatory Officer Division of Allergy, Immunology and Transplantation John Silva, MD National Institute of Allergy and Infectious Diseases Silva Consulting Services National Institutes of Health [email protected] U.S. Department of Health and Human Services [email protected] Ida-Maria Sintorn, PhD Head of Image Analysis Sushil Sharma, DrPH, PhD Vironova AB Assistant Director [email protected] U.S. Government Accountability Office [email protected] Alexander Sinyakov, PhD Head Alan Shaw, PhD Institute of Chemical Biology and Fundamental Medicine President and Chief Executive Officer [email protected] VaxInnate [email protected] Ben Sloan Director, Government Affairs Karen Shaw, PhD Salix Pharmaceuticals Vice President Biology [email protected] Trius Therapeutics, Inc. [email protected] Nelly Smirnova International Science and Technology Center Roger Shaw, BSc, CHP [email protected] Senior Technical Advisor Radiation Detection Company, Inc. Brad Smith, PhD [email protected] Senior Associate Center for Biosecurity of the University of Pittsburgh Dana Shea Medical Center Congressional Research Service [email protected] U.S. Library of Congress [email protected] 20 Jonathan Smith, PhD Boyd Stephenson Chief Scientific Operations Manager Security and Cross Border Operations AlphaVax, Inc. American Trucking Associations [email protected] [email protected]

Mark Smith, MD, FACEP Mark Stidham, PhD Chairman, Division of Emergency Medicine Director Washington Hospital Center Trius Therapeutics [email protected] [email protected]

Jacqueline Solaita Robin Stombler Hospital Preparedness Program Coordinator President American Samoa Department of Health Auburn Health Strategies, LLC [email protected] [email protected]

Bryony Soltis, MD, MPH Don Straus, PhD Center for Health Promotion and Preventive Medicine Chief Scientific Officer U.S. Army First Light Biosciences U.S. Department of Defense [email protected] [email protected] Barbara Styrt, MD, MPH Francis Souter, MD, MHsc Medical Officer Program Officer U.S. Food and Drug Administration Biological Warfare Medical Countermeasures U.S. Department of Health and Human Services Department of National Defence, Canada [email protected] [email protected] Lewis Suiter, PhD Yvette Edghill Spano, PhD Consultant Project Leader [email protected] Southern Research [email protected] Sean Sullivan, BS Senior Graduate Researcher Beth Spinelli, MS Georgia Institute of Technology Program Officer [email protected] National Institute of Allergy and Infectious Diseases National Institutes of Health Timothy Sullivan U.S. Department of Health and Human Services President and Chief Executive Officer [email protected] Mystic Pharmaceuticals, Inc. [email protected] Laura St. Martin, MD, MPH Medical Officer Gerd Sutter U.S. Food and Drug Administration Division of Virology U.S. Department of Health and Human Services Paul-Ehrlich-Institut [email protected] [email protected]

Andrea Stahl, PhD Alan Taggart Chief, Integrated Toxicology Division MedImmune, Inc. United States Army Medical Research Institute of [email protected] Infectious Diseases U.S. Department of Defense Ernest Takafuji, MD, MPH [email protected] Director, Office of Biodefense Research Office of the Director Jeffrey Stein, PhD National Institute of Allergy and Infectious Diseases President and Chief Executive Officer National Institutes of Health Trius Therapeutics U.S. Department of Health and Human Services [email protected] [email protected]

Eric Stephen James Talton, PhD Defence R&D Canada’s Nucleic Acid-Based Chief Executive Officer Anti-Viral Program Nanotherapeutics [email protected] [email protected]

Tim Stephens Public Health Advisor National Sheriffs Association [email protected] 21 Xiaolian Tan, PhD Susana P. Tinsay, MD Principal Investigator Director, Emergency Preparedness U.S. Army Medical Research Institute of Infectious Diseases New Parkway Hospital U.S. Department of Defense [email protected] [email protected] Robert To, PhD Glen Tao, PharmD Senior Scientist Strategic National Stockpile Coordinator XOMA (US) LLC County of Los Angeles (California) Department of Public Health [email protected] [email protected] Saito Tomoya, MD, MPH Irach Taraporewala, PhD, MS, BS Bio-Preparedness Research Laboratory Vice President, Regulatory Affairs and Clinical [email protected] Research Mystic Pharmaceuticals John Topping [email protected] Senior Advisor, Global Health Security Initiative International Affairs Directorate, Health Canada David Taylor, MD [email protected] Chief Medical Officer VaxInnate Derek Toth [email protected] Manager, Bio/Immuno Assay Development BioAnalytical Research and Development Katherine Taylor, PhD Cangene Corporation Chief, Drug Development Section [email protected] National Institute of Allergy and Infectious Diseases National Institutes of Health Carol Trapnell, MD U.S. Department of Health and Human Services Chief Medical Officer [email protected] SAJE Consulting, LLC [email protected] Robert Tenerowicz, MBA Vice President Cheryl Turner, RN, BS XOMA (US) LLC Regulatory Project Manager [email protected] Center for Drug Evaluation and Research U.S. Food and Drug Administration Kathy Terlesky, PhD U.S. Department of Health and Human Services Deputy Chief Technical Officer [email protected] Science Applications International Corporation [email protected] Lynda Tussey, PhD Vice President, Immunology Meridith Thanner, PhD VaxInnate Research Associate, CEPAR/PACER [email protected] Johns Hopkins University [email protected] Paula Underwood, BS, MD, MPH, MHA Army Surgeon General Liaison Officer Wayne Theurer, BA Office of the Army Surgeon General 1SG - Senior Operations Analyst U.S. Department of Health and Human Services 32 CST-WMD Response Team [email protected] U.S. Army U.S. Department of Defense Katherine Uraneck, MD [email protected] Senior Medical Coordinator New York City Department of Health and Mental Hygiene Kristina Thiagarajan, PhD, MN, RN [email protected] Program Director Oak Ridge National Laboratory Andrea Valenta, MSN, RN [email protected] Washington Hospital Center [email protected] Arul Thilagar, PhD Vice President, Preclinical Development RADM W. Craig Vanderwagen, MD Summit Drug Development Services Assistant Secretary for Preparedness and Response [email protected] U.S. Department of Health and Human Services [email protected] Nigel Thomas Intercell USA, Inc. MAJ Don Van Loon [email protected] Defence Research and Development Canada [email protected] 22 Elaine Vaurio, MA Gregory Went, PhD Senior Analyst, Center for Technology and Engineering Chairman and Chief Executive Officer U.S. Government Accountability Office Adamas Pharmaceuticals, Inc. [email protected] [email protected]

Matthew Veatch David Werner, JD Senior Director, Public Health and Government Services Consultant Quintiles Gencarelli Group [email protected] [email protected]

Keith Vesely, DVM, PhD Robert Whitcomb, PhD Director, U.S. Army Veterinary Corps Lead Physical Scientist Office of the Assistant Secretary of Defense for Health Affairs Centers for Disease Control and Prevention U.S. Department of Defense U.S. Department of Health and Human Services [email protected] [email protected]

Ulyana Vjugina, PhD Kevin Whittlesey, PhD Senior Program Associate Office of Representative Anna Eshoo National Academy of Sciences [email protected] [email protected] David Wilder, DO, MPH Abdul Wajid, PhD Regional Medical Officer Senior Director, Process Sciences Virginia Department of Health XOMA (US) LLC [email protected] [email protected] Nancy Wilkie, MS Hilary Walker, PhD Project Officer, Product Development Head, Radiation, Chemical and Division of Microbiology and Infectious Diseases Environmental Hazards National Institute of Allergy and Infectious Diseases Department of Health, United Kingdom National Institutes of Health [email protected] U.S. Department of Health and Human Services [email protected] Katherine Wallace, PharmD Senior Health Policy Advisor Diana Wilkinson U.S. Department of Veterans Affairs Defence R&D Canada - Ottawa [email protected] [email protected]

Kelly Warfield, PhD COL David Williams Vice President of Vaccine Development Joint Project Manager Integrated BioTherapeutics Inc. Computer-Based Medical Systems Army [email protected] U.S. Department of Defense [email protected] Heather Wargo, MS Defense Threat Reduction Agency Samantha Williams U.S. Department of Defense Public Health Analyst [email protected] Centers for Medicare and Medicaid Services U.S. Department of Health and Human Services William Warren, PhD [email protected] President and Chief Executive Officer VaxDesign Corporation Mark Williamson, BSc, MSc, PhD [email protected] Deputy Director General Centre for Security Science, Defence Research, and Dorothy Wawrose, MD Development Canada Medical Officer [email protected] U.S. Food and Drug Administration U.S. Department of Health and Human Services Constance Wilson, MD [email protected] Chief Scientific Officer Endacea, Inc. Michael Wells, MS, MBA [email protected] Chief Executive Officer Aton Pharma, Inc. Don Wilson, MBA, JD [email protected] President, Chief Executive Officer and General Counsel Endacea, Inc. [email protected]

23 Joshua Wolfe Walter Zielinski, PhD Applied Physics Laboratory Senior Scientist Program Development Johns Hopkins University Mystic Pharmaceuticals, Inc. [email protected] [email protected]

Alan Wolfman, PhD Janelle Zimmerman Director of Business Development Human Genome Sciences Cleveland Biolabs, Inc. [email protected] [email protected] Kathy Zito, PhD David Woodard, BS Product Manager Medical Technologist DND Canada Federal Bureau of Prisons [email protected] U.S. Department of Justice [email protected]

David Wurtman, MD, MBA Vice President, Corporate Development

NexBio, Inc. [email protected]

Edward Yamin, MD Chairman, Disaster Preparedness Committee Hackensack University Medical Center [email protected]

Debra A. Yeskey, PharmD Director, Regulatory and Quality Affairs Division Biomedical Advanced Research and Development Authority Office of the Assistant Secretary for Preparedness and Response U.S. Department of Health and Human Services [email protected]

Kevin Yeskey, MD Deputy Assistant Secretary for Preparedness and Response Director, Office of Planning and Emergency Operations U.S. Department of Health and Human Services [email protected]

Hiroyuki Yokote Chemo-Sero-Therapeutic Research Institute [email protected]

Donna Young Washington Editor BioWorld Today/AHC Media, LLC [email protected]

Lloyd Yu, PhD Director Process and Development Planet Biotechnology, Inc. [email protected]

Yon Yu, PharmD Deputy Chief, Regulatory Affairs Centers for Disease Control and Prevention U.S. Department of Health and Human Services [email protected]

Vidadi Yusibov Integrated BioPharma, Inc. [email protected]

24 inside back cover blank U.S. Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response Biomedical Advanced Research and Development Authority